Serum Lenvatinib and Interleukin-6 Profiles and Their Relationship With Acute Heart Failure Development in a Patient With Thymic Carcinoma and Cancer Inflammation
These findings suggest that elevated serum IL-6 levels lead to delayed elimination of lenvatinib. The increased serum levels of both lenvatinib and IL-6 may be associated with the development of acute heart failure in patients with thymic carcinoma.
Authors
- Tomonobu Koizumi
- Yasuaki Mino (ORCID: https://orcid.org/0000-0002-5706-1117)
- Takafumi Naito (ORCID: https://orcid.org/0000-0002-7447-3789)
- Mitsutoshi Asakura
- Takashi Kobayashi (ORCID: https://orcid.org/0000-0002-9039-0465)
- Natsumi Seki
Institutions
- Shinshu University (JP)
- Hamamatsu University School of Medicine (JP)
- Shinshu University Hospital (JP)
Publication Details
- Journal
- Therapeutic Drug Monitoring
- Published
- 2025-05-02
- DOI
- https://doi.org/10.1097/ftd.0000000000001335
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00